MRNA

Moderna
MRNA

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
$10.31B
EV
$2.67B
Shares Outstanding
386.74M
Beta
1.86

Wall Street View

Analyst Rating
HOLD
Analyst Target Price
$47.59
P/E 2025E
-
P/Revenue 2025E
4.98x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Moderna, Inc.

gainify
MRNA

Moderna, Inc.

MRNA

Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, autoimmune, and cardiovascular diseases in the United States, Europe, and ...

Sector

Healthcare

Industry

Biotechnology

CEO

Bancel, Stephane

Employees

5,800

IPO Date

2018-12-07

Headquarters

200 Technology Square, Cambridge, Massachusetts, 02139, United States

gainify
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on ThreadsCheck us out on Trustpilot
powered-by-sp

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2025 Gainify. All rights reserved.